We are transforming cancer diagnostics by providing innovative, scalable, and low-cost solutions tailored for growing economies. At Raiz Diagnostics, we focus on high-impact cancers like lymphomas—challenging to diagnose, with variable treatment strategies. Our flagship product, LymphomaDx, leverages targeted genomic analysis and AI-powered interpretation to deliver accurate, treatment-relevant diagnoses without relying on costly stains or local hematopathologists.
By utilizing standard lab equipment and an all-in-one IVD kit, our approach eliminates the barriers of traditional diagnostics, offering centralized data entry and quality control through a secure, cloud-based platform. This enables faster, more accessible diagnostics at a fraction of the cost, making it ideal for middle-income countries that already invest in limited cancer diagnostics but need scalable, affordable solutions.
With LymphomaDx, we’re not just raising the bar for cancer diagnostics—we’re raising global access.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://raizdx.com
- Keywords
- Nahant.
Raiz Diagnostics Questions
Raiz Diagnostics's website is http://raizdx.com
Raiz Diagnostics's LinkedIn profile is https://www.linkedin.com/company/raizdx
Raiz Diagnostics has
1 employees.
View email and phone details for 1
employees at Raiz Diagnostics.
Raiz Diagnostics's industry is
Biotechnology Research
Raiz Diagnostics's top competitors are
Dana-Farber Cancer Institute,
Ispe Boston Area Chapter,
Ocean Genome Legacy Center.
Raiz Diagnostics's categories are Biotechnology Research
Raiz Diagnostics's founding year is 2024
